Sweet, yet underappreciated: Proteoglycans and extracellular matrix remodeling in heart disease.
暂无分享,去创建一个
[1] John Wikstrand,et al. Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trial. , 2015, Journal of cardiac failure.
[2] Douglas P. Zipes,et al. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 10th Edition , 2011 .
[3] Bing Liu,et al. Identification of nondiabetic heart failure-associated genes by bioinformatics approaches in patients with dilated ischemic cardiomyopathy. , 2016, Experimental and therapeutic medicine.
[4] M. Loebe,et al. Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[5] S. Apte,et al. The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[6] M. Wong,et al. Loss of glypican-3 function causes growth factor-dependent defects in cardiac and coronary vascular development. , 2009, Developmental biology.
[7] A. McCulloch,et al. The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart , 2017, Journal of clinical medicine.
[8] R. Iozzo,et al. Heparanase: multiple functions in inflammation, diabetes and atherosclerosis. , 2013, Matrix biology : journal of the International Society for Matrix Biology.
[9] K. Otsu,et al. Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis , 2017, Circulation.
[10] J. Couchman,et al. Transmembrane signaling proteoglycans. , 2010, Annual review of cell and developmental biology.
[11] M. Okada,et al. Induction of heparanase gene expression in ventricular myocardium of rats with isoproterenol-induced cardiac hypertrophy. , 2005, Biological & pharmaceutical bulletin.
[12] Jeffrey D. Esko,et al. Heparan sulphate proteoglycans fine-tune mammalian physiology , 2007, Nature.
[13] Sylvie Ricard-Blum,et al. Heparin-protein interactions: from affinity and kinetics to biological roles. Application to an interaction network regulating angiogenesis. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[14] R. Weksberg,et al. Cardiac anomalies in the Simpson-Golabi-Behmel syndrome. , 1999, American journal of medical genetics.
[15] C. Carlson,et al. Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan‐4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure‐overloaded heart , 2013, The FEBS journal.
[16] S. Selleck,et al. Glypicans: proteoglycans with a surprise. , 2001, The Journal of clinical investigation.
[17] Jian Liu,et al. Multi-faceted substrate specificity of heparanase. , 2013, Matrix biology : journal of the International Society for Matrix Biology.
[18] Thomas de Quincey. [C] , 2000, The Works of Thomas De Quincey, Vol. 1: Writings, 1799–1820.
[19] L. Birnbaumer,et al. A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo. , 2012, Developmental cell.
[20] Reza Razavi,et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. , 2013, JACC. Cardiovascular imaging.
[21] C. Carlson,et al. Syndecan-4 Regulates Muscle Differentiation and Is Internalized from the Plasma Membrane during Myogenesis , 2015, PloS one.
[22] P. Carmeliet,et al. Increased Expression of Syndecan-1 Protects Against Cardiac Dilatation and Dysfunction After Myocardial Infarction , 2007, Circulation.
[23] Avadhesha Surolia,et al. N-linked oligosaccharides as outfitters for glycoprotein folding, form and function. , 2006, Trends in biochemical sciences.
[24] R. Stewart,et al. Myocardial microvascular permeability, interstitial oedema, and compromised cardiac function. , 2010, Cardiovascular research.
[25] R. Iozzo,et al. Biological interplay between proteoglycans and their innate immune receptors in inflammation , 2013, The FEBS journal.
[26] A. Baxova,et al. Parental consanguinity in two sibs with omodysplasia. , 1994, American journal of medical genetics.
[27] R. Markwald,et al. Transforming growth factor β1 (TGFβ1) regulates CD44V6 expression and activity through extracellular signal-regulated kinase (ERK)-induced EGR1 in pulmonary fibrogenic fibroblasts , 2017, The Journal of Biological Chemistry.
[28] Renato V. Iozzo,et al. Proteoglycan form and function: A comprehensive nomenclature of proteoglycans , 2015, Matrix biology : journal of the International Society for Matrix Biology.
[29] S. Klewer,et al. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. , 2000, The Journal of clinical investigation.
[30] S. Faust,et al. TGFβ Neutralization within Cardiac Allografts by Decorin Gene Transfer Attenuates Chronic Rejection1 , 2009, The Journal of Immunology.
[31] C. H. Conrad,et al. Transition from compensated hypertrophy to systolic heart failure in the spontaneously hypertensive rat: Structure, function, and transcript analysis. , 2010, Genomics.
[32] A. Baggish,et al. Measurement of Novel Biomarkers to Predict Chronic Heart Failure Outcomes and Left Ventricular Remodeling , 2014, Journal of Cardiovascular Translational Research.
[33] I. Sjaastad,et al. The Heparan Sulfate Proteoglycan Glypican-6 Is Upregulated in the Failing Heart, and Regulates Cardiomyocyte Growth through ERK1/2 Signaling , 2016, PloS one.
[34] C. Carlson,et al. Pentosan Polysulfate Decreases Myocardial Expression of the Extracellular Matrix Enzyme ADAMTS4 and Improves Cardiac Function In Vivo in Rats Subjected to Pressure Overload by Aortic Banding , 2014, PloS one.
[35] W. Linke,et al. Syndecan-4 is a key determinant of collagen cross-linking and passive myocardial stiffness in the pressure-overloaded heart. , 2015, Cardiovascular research.
[36] Y. Matsui,et al. Syndecan-4 Prevents Cardiac Rupture and Dysfunction After Myocardial Infarction , 2011, Circulation research.
[37] A. DeMaria,et al. Safety and Efficacy of an Injectable Extracellular Matrix Hydrogel for Treating Myocardial Infarction , 2013, Science Translational Medicine.
[38] Z. Naito. Role of the small leucine-rich proteoglycan (SLRP) family in pathological lesions and cancer cell growth. , 2005, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.
[39] K. Chatila,et al. CD44 Is Critically Involved in Infarct Healing by Regulating the Inflammatory and Fibrotic Response1 , 2008, The Journal of Immunology.
[40] G. Christensen,et al. Syndecans in heart fibrosis , 2016, Cell and Tissue Research.
[41] J. Beckmann,et al. Mutations in the heparan-sulfate proteoglycan glypican 6 (GPC6) impair endochondral ossification and cause recessive omodysplasia. , 2009, American journal of human genetics.
[42] J. Spring,et al. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. , 1992, Annual review of cell biology.
[43] M. Mavroidis,et al. Extensive induction of important mediators of fibrosis and dystrophic calcification in desmin-deficient cardiomyopathy. , 2002, The American journal of pathology.
[44] Sylvain D. Vallet,et al. Decorin interacting network: A comprehensive analysis of decorin-binding partners and their versatile functions. , 2016, Matrix biology : journal of the International Society for Matrix Biology.
[45] J. Filmus,et al. Glypicans in growth control and cancer. , 2001, Glycobiology.
[46] J. Fischer,et al. Accumulation and Loss of Extracellular Matrix During Shear Stress-mediated Intimal Growth and Regression in Baboon Vascular Grafts , 2005 .
[47] Danna Zhou,et al. d. , 1840, Microbial pathogenesis.
[48] H. Sakuma,et al. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy. , 2018, JACC. Cardiovascular imaging.
[49] I. Sjaastad,et al. Decorin, lumican, and their GAG chain-synthesizing enzymes are regulated in myocardial remodeling and reverse remodeling in the mouse. , 2013, Journal of applied physiology.
[50] P. Alam. ‘A’ , 2021, Composites Engineering: An A–Z Guide.
[51] I. Sjaastad,et al. Lack of Chemokine Signaling through CXCR5 Causes Increased Mortality, Ventricular Dilatation and Deranged Matrix during Cardiac Pressure Overload , 2011, PloS one.
[52] V. Dolinsky,et al. See Clinical Perspective , 2022 .
[53] B. Aronow,et al. Genetic lineage tracing defines myofibroblast origin and function in the injured heart , 2016, Nature Communications.
[54] R. Sanderson,et al. Heparan sulfate in the nucleus and its control of cellular functions. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[55] L. Kiesel,et al. An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ , 2007, Breast Cancer Research.
[56] C. Little,et al. Proteoglycan degradation by the ADAMTS family of proteinases. , 2011, Biochimica et biophysica acta.
[57] Dudley J Pennell,et al. Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass , 2008, Nature Genetics.
[58] I. Edwards. Proteoglycans in prostate cancer , 2012, Nature Reviews Urology.
[59] A. DeMaria,et al. Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. , 2012, Journal of the American College of Cardiology.
[60] M. Banach,et al. Heart failure biomarkers in patients with dilated cardiomyopathy. , 2013, International journal of cardiology.
[61] G. Gambaro,et al. Impact of heparanase on renal fibrosis , 2015, Journal of Translational Medicine.
[62] N. Frangogiannis,et al. Transforming growth factor (TGF)-β signaling in cardiac remodeling. , 2011, Journal of molecular and cellular cardiology.
[63] G. Conrad,et al. Effects of Ultraviolet-A and Riboflavin on the Interaction of Collagen and Proteoglycans during Corneal Cross-linking* , 2011, The Journal of Biological Chemistry.
[64] M. Götte,et al. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways , 2017, Molecular Cancer.
[65] W. Kao,et al. Lumican-null mice are susceptible to aging and isoproterenol-induced myocardial fibrosis. , 2014, Biochemical and biophysical research communications.
[66] S. Chakravarti. Functions of lumican and fibromodulin: Lessons from knockout mice , 2002, Glycoconjugate Journal.
[67] S. Djurovic,et al. Syndecan-4 Is Essential for Development of Concentric Myocardial Hypertrophy via Stretch-Induced Activation of the Calcineurin-NFAT Pathway , 2011, PloS one.
[68] N. Hiraiwa,et al. Versican/PG-M is essential for ventricular septal formation subsequent to cardiac atrioventricular cushion development. , 2012, Glycobiology.
[69] Pei-hua Wang,et al. Decorin gene delivery inhibits cardiac fibrosis in spontaneously hypertensive rats by modulation of transforming growth factor-beta/Smad and p38 mitogen-activated protein kinase signaling pathways. , 2009, Human gene therapy.
[70] M. Gotte,et al. Heparan sulphate as a regulator of leukocyte recruitment in inflammation. , 2015, Current protein & peptide science.
[71] Stephane Heymans,et al. Myocardial Extracellular Matrix: An Ever-Changing and Diverse Entity , 2014, Circulation research.
[72] S. Preissl,et al. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload. , 2016, Journal of molecular and cellular cardiology.
[73] S. Apte. A Disintegrin-like and Metalloprotease (Reprolysin-type) with Thrombospondin Type 1 Motif (ADAMTS) Superfamily: Functions and Mechanisms* , 2009, The Journal of Biological Chemistry.
[74] G. Nepom,et al. Cutting Edge: High Molecular Weight Hyaluronan Promotes the Suppressive Effects of CD4+CD25+ Regulatory T Cells1 , 2007, The Journal of Immunology.
[75] T. Ueland,et al. Role of inflammation in the progression of heart failure , 2007, Current cardiology reports.
[76] M. Okada,et al. Aberrant gene expression of heparanase in ventricular hypertrophy induced by monocrotaline in rats , 2015, The Journal of veterinary medical science.
[77] S. Heymans,et al. The diverse functions of osteoglycin: a deceitful dwarf, or a master regulator of disease? , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[78] M. Götte,et al. Shed proteoglycans in tumor stroma , 2016, Cell and Tissue Research.
[79] Robert H. Jenkins,et al. Modulation of TGFbeta1-dependent myofibroblast differentiation by hyaluronan. , 2009, The American journal of pathology.
[80] C. Kim,et al. Omodysplasia: the first reported Brazilian case. , 2007, Clinics.
[81] Biljana Skrbic,et al. Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli , 2013, The FEBS journal.
[82] O. Griesbeck,et al. Transmembrane proteoglycans control stretch-activated channels to set cytosolic calcium levels , 2015, The Journal of cell biology.
[83] R. D. de Boer,et al. From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities , 2017, Current Heart Failure Reports.
[84] Long He,et al. The advancements of heparanase in fibrosis. , 2016, International journal of molecular epidemiology and genetics.
[85] H. Haubeck. Decorin , 2020, Definitions.
[86] N. Karamanos,et al. Glycosaminoglycans: from "cellular glue" to novel therapeutical agents. , 2012, Current opinion in pharmacology.
[87] S. Paine-Saunders,et al. GPC6, a novel member of the glypican gene family, encodes a product structurally related to GPC4 and is colocalized with GPC5 on human chromosome 13. , 1999, Genomics.
[88] C. Carlson,et al. Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress. , 2013, Journal of molecular and cellular cardiology.
[89] T. Rabelink,et al. Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease , 2017, Nature Reviews Nephrology.
[90] H. Nothaft,et al. Protein glycosylation in bacteria: sweeter than ever , 2010, Nature Reviews Microbiology.
[91] Jian Li,et al. Increased syndecan expression following myocardial infarction indicates a role in cardiac remodeling. , 2004, Physiological genomics.
[92] J. Omens,et al. Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment. , 2016, Journal of the American College of Cardiology.
[93] Raymond M. Wang,et al. Decellularized myocardial matrix hydrogels: In basic research and preclinical studies. , 2016, Advanced drug delivery reviews.
[94] Gregory M. Fomovsky,et al. Contribution of extracellular matrix to the mechanical properties of the heart. , 2010, Journal of molecular and cellular cardiology.
[95] Xiao Han,et al. Overexpression of heparanase multiple antigenic peptide 2 is associated with poor prognosis in gastric cancer: Potential for therapy. , 2012, Oncology Letters.
[96] R. Watson,et al. T-lymphocytes mediate left ventricular fibrillar collagen cross-linking and diastolic dysfunction in mice. , 2010, Matrix biology : journal of the International Society for Matrix Biology.
[97] Jin-ping Li,et al. Implications of heparan sulfate and heparanase in neuroinflammation. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[98] M. Kurabayashi,et al. Serum syndecan-4 is a novel biomarker for patients with chronic heart failure. , 2011, Journal of cardiology.
[99] L. Dupuis,et al. Small leucine‐rich proteoglycans exhibit unique spatiotemporal expression profiles during cardiac valve development , 2014, Developmental dynamics : an official publication of the American Association of Anatomists.
[100] J. Rast,et al. Glypicans , 2008, Genome Biology.
[101] N. Frangogiannis,et al. The inflammatory response in myocardial injury, repair, and remodelling , 2014, Nature Reviews Cardiology.
[102] J. Filmus,et al. Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface. , 2008, The Biochemical journal.
[103] R. Iozzo,et al. Biological Functions of the Small Leucine-rich Proteoglycans: From Genetics to Signal Transduction* , 2008, Journal of Biological Chemistry.
[104] P. Alam. ‘S’ , 2021, Composites Engineering: An A–Z Guide.
[105] Guangping Chen,et al. Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression. , 2004, Biochemistry.
[106] G. Prestwich,et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan , 2005, Nature Medicine.
[107] R. V. van Leeuwen,et al. Osteoglycin Prevents Cardiac Dilatation and Dysfunction After Myocardial Infarction Through Infarct Collagen Strengthening , 2015, Circulation research.
[108] A. Fico,et al. Fine-tuning of cell signaling by glypicans , 2011, Cellular and Molecular Life Sciences.
[109] J. Leenders,et al. Syndecan-1 Amplifies Angiotensin II–Induced Cardiac Fibrosis , 2010, Hypertension.
[110] R. D. de Boer,et al. Fibrosis Marker Syndecan-1 and Outcome in Patients With Heart Failure With Reduced and Preserved Ejection Fraction , 2014, Circulation. Heart failure.
[111] G. Gambaro,et al. Recent data concerning heparanase: focus on fibrosis, inflammation and cancer , 2015, Biomolecular concepts.
[112] Ying Wang,et al. Endothelial Cell Heparanase Taken Up by Cardiomyocytes Regulates Lipoprotein Lipase Transfer to the Coronary Lumen After Diabetes , 2014, Diabetes.
[113] B. Rodrigues,et al. High glucose facilitated endothelial heparanase transfer to the cardiomyocyte modifies its cell death signature. , 2016, Cardiovascular research.
[114] Z. Borochowitz,et al. Familial congenital micromelic dysplasia with dislocation of radius and distinct face: a new skeletal dysplasia syndrome. , 1991, American journal of medical genetics.
[115] Richard J. R. Kelwick,et al. The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family , 2015, Genome Biology.
[116] M. Santha,et al. The Role of Biglycan in the Heart , 2008, Connective tissue research.
[117] S. Heymans,et al. A novel 72-kDa leukocyte-derived osteoglycin enhances the activation of toll-like receptor 4 and exacerbates cardiac inflammation during viral myocarditis , 2016, Cellular and Molecular Life Sciences.
[118] G. Gambaro,et al. Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. , 2014, Biochimica et biophysica acta.
[119] H. Saito,et al. Plasma Levels of Syndecan-4 (Ryudocan) Are Elevated in Patients with Acute Myocardial Infarction , 2001, Thrombosis and Haemostasis.
[120] R. Goldberg,et al. Versatile role of heparanase in inflammation. , 2013, Matrix biology : journal of the International Society for Matrix Biology.
[121] M. Banach,et al. The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension , 2015, International journal of molecular sciences.
[122] Doris A Taylor,et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart , 2008, Nature Medicine.
[123] I. Sjaastad,et al. Shedding of syndecan-4 promotes immune cell recruitment and mitigates cardiac dysfunction after lipopolysaccharide challenge in mice. , 2015, Journal of molecular and cellular cardiology.
[124] Yuling Zhang,et al. Sdc1 Overexpression Inhibits the p38 MAPK Pathway and Lessens Fibrotic Ventricular Remodeling in MI Rats , 2013, Inflammation.
[125] T. Wight,et al. Pivotal role for decorin in angiogenesis. , 2015, Matrix biology : journal of the International Society for Matrix Biology.
[126] V. Lokeshwar,et al. The Role of CD44 in Disease Pathophysiology and Targeted Treatment , 2015, Front. Immunol..
[127] R. Lüllmann-Rauch,et al. Biglycan Is Required for Adaptive Remodeling After Myocardial Infarction , 2008, Circulation.
[128] M. Young,et al. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. , 1989, The Journal of biological chemistry.
[129] I. Kang,et al. Versican and the control of inflammation. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[130] A. Lupo,et al. Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545 , 2017, Oncotarget.
[131] D. Schlessinger,et al. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome , 1996, Nature Genetics.
[132] A. Yndestad,et al. Induction of myocardial biglycan in heart failure in rats--an extracellular matrix component targeted by AT(1) receptor antagonism. , 2003, Cardiovascular research.
[133] A. Wilkie,et al. Recessive omodysplasia: five new cases and review of the literature , 2004, Pediatric Radiology.
[134] P. Park,et al. Molecular functions of syndecan-1 in disease. , 2012, Matrix biology : journal of the International Society for Matrix Biology.